Previous close | 5.20 |
Open | 5.20 |
Bid | 5.40 |
Ask | 7.80 |
Strike | 60.00 |
Expiry date | 2024-12-20 |
Day's range | 5.20 - 5.20 |
Contract range | N/A |
Volume | |
Open interest | 74 |
Fady Malik, Executive Vice President of Research & Development at Cytokinetics Inc (NASDAQ:CYTK), sold 7,788 shares of the company on June 11, 2024.
On June 10, 2024, Muna Bhanji, a Director at Cytokinetics Inc (NASDAQ:CYTK), sold 2,000 shares of the company at a price of $52.07 per share.
On June 3, 2024, B Parshall, Director at Cytokinetics Inc (NASDAQ:CYTK), executed a sale of 5,000 shares of the company.